ChemotherapyPhase 3 trialInvestigational
Doxorubicin
How it works
Interferes with cell division, preventing cancer cells from growing and dividing.
Cancer types
Breast Cancer— All patients
Side effects
Severe
This treatment carries a higher risk of serious side effects. Close medical monitoring is required throughout treatment.
Evidence from research
| Study | Cancer type | Stage | Efficacy | |
|---|---|---|---|---|
| Understanding Resistance to Doxorubicin in Triple-Negative Breast Cancer | Breast Cancer | lab-study | — | Source → |
| Pegylated Liposomal Doxorubicin and Immunotherapy in Recurrent Ovarian Cancer | Ovarian Cancer | phase-2 | — | Source → |
| Detecting Cancer Drug Concentration in Cells | Breast Cancer | lab-study | — | Source → |
| Overcoming Doxorubicin Resistance in Ovarian Cancer Cells | Ovarian Cancer | lab-study | Substantial resensitization of A2780ADR cells to Doxo was achieved by verapamil (Ver). | Source → |
| Doxorubicin Resistance in Triple-Negative Breast Cancer | Breast Cancer | lab-study | — | Source → |
| Combining drugs may help fight aggressive breast cancer | Breast Cancer | lab-study | Treatment with SB431542 and doxorubicin used in combination significantly reduced cell viability (CDI 0.54-0.63) | Source → |
| New Delivery System for Colorectal Cancer Treatment | Colorectal Cancer | lab-study | The tumor suppression rate reached 42.55 ± 0.18%. | Source → |
| Long non-coding RNA STMN1P2 linked to breast cancer resistance to doxorubicin | Breast Cancer | lab-study | — | Source → |
| New Compound Shows Promise in Treating Prostate Cancer | Prostate Cancer | lab-study | — | Source → |
| Dichloroacetate Enhances Chemotherapy Effectiveness in Some Breast Cancer Cells | Breast Cancer | lab-study | The cell line MCF7 exhibited the highest rate of inhibition, followed by MDA-MB-231 and T47D. | Source → |
| Doxorubicin's kidney damage linked to SIRT1/HSF1 pathway | Ovarian Cancer | animal-study | — | Source → |
| Ovarian Cancer and Heart Damage: New Research and Treatment Strategies | Ovarian Cancer | review | — | Source → |
| Targeting Prion Protein to Overcome Chemotherapy Resistance in Lung Cancer | Lung Cancer | lab-study | — | Source → |
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.